top of page

HCC1954 Xenograft Model

Rincon Bio offers efficacy studies using the HCC1954 Xenograft Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Xenograft
Organ:
Breast
Derivation:
Epithelial line from a primary stage IIA ductal carcinoma in a 61yo female with no lymph node metastases
Mutations:
PIK3CA, TP53, CLTC-VMP1 fusion
NCI60:
No
Weeks from stratification to termination (average):
7

HCC1954 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the HCC1954 xenograft model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page